comprehensive
Previous article:
Duchenne breakthrough therapy leaves behind pioneering families
Next article: Burning questions for the 2024 JPM Healthcare Conference
Next article: Burning questions for the 2024 JPM Healthcare Conference
focus
explore
-
AltruBio raises $225 million to develop ulcerative colitis drug
2025-09-28 21:51 -
U.K. sequencing study surfaces new findings about tumor DNA
2025-09-28 21:13 -
The creative science of coining drug names
2025-09-28 21:04 -
Empower primary care with adequate payments and technology
2025-09-28 20:49 -
Goldman Sachs launches $650M fund for life science investments
2025-09-28 20:40 -
Is it ever OK for doctors to lie to their patients?
2025-09-28 20:19